03:46 PM EST - Stem Cell Therapeutics Corp. : said it received two patents in India. The patents are Indian Patent No. 229684 entitled, Combined Regulation of Neural Cell Production and Indian Patent No. 229924 entitled, A Composition for Increasing Neural Stem Cell Number and In Vitro Method of Using the Same.
The company noted that, these patents cover pharmaceutical compositions for increasing neural stem cell number or for producing specialized neural stem cell progeny, with the compositions comprising prolactin in combination with other neural stem cell proliferating agents or differentiating agents, such as erythropoietin. Stem Cell Therapeutics Corp.
shares V.SSS are trading up $0.015 at $0.17.
